IP Verse

Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments - EP2439285

PATENT ANALYSIS

Patent Details

Grant Date
May 8, 2019
Company
DANA-FARBER CANCER INSTITUTE, INC.
Oppositions

BOULT WADE TENNANT LLP

JAMES POOLE LIMITED

More patents of Dana-Farber Cancer Institute, Inc.

EP3506884

EP3023788

EP2423331

Want to monitor this patent?

Feel free to send us a message here and we will get back to you